George Siber

Scientific Founder at Affinivax, Inc.

George Siber

George Siber

Scientific Founder at Affinivax, Inc.

Overview
Career Highlights

Genocea Biosciences, Inc.
Affinivax, Inc.

RelSci Relationships

2899

Number of Boards

14

Birthday

1945

Age

75

Contact Data
Trying to get in touch with George Siber? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals George Siber likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer & Director at Affinivax, Inc.

Relationship likelihood: Strong

Scientific Founder at Affinivax, Inc.

Relationship likelihood: Strong

Scientific Co-Founder at Vaxess Technologies, Inc.

Relationship likelihood: Strong

Professor at Harvard University

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Genocea Biosciences, Inc.

Relationship likelihood: Strong

Founder at Good2Go LLC

Relationship likelihood: Strong

Co-Founder at Lux Capital Group LLC

Relationship likelihood: Strong

Co-Founder & Managing Partner at Lux Capital Group LLC

Relationship likelihood: Strong

Managing Director at Alta Partners Management Corp.

Relationship likelihood: Strong

Director General at International Vaccine Institute

Relationship likelihood: Strong

Paths to George Siber
Potential Connections via
Relationship Science
You
George Siber
Scientific Founder at Affinivax, Inc.
Education

Bishop's University is a predominantly undergraduate university in Lennoxville, Sherbrooke, Quebec, Canada.

MD

The Faculty of Medicine is one of the constituent faculties of McGill University. It was established in 1823 as the Montreal Medical Institution, and became the first faculty of McGill College in 1829; it was the first medical faculty to be established in Canada. The Faculty awarded McGill's first degree, and Canada's first medical degree to William Leslie Logie in 1833. The faculty includes three schools, the School of Communication Sciences and Disorders, School of Nursing, and the School of Physical and Occupational Therapy. It also includes several research centres involved in studies on, for example, pain, neuroscience, and aging. Most of the non-clinical parts of the faculty are housed in the McIntyre Medical Sciences Building ("The Beer Can"), situated on McGill's downtown campus on the south side of Mount Royal between Avenue des Pins and Avenue Docteur-Penfield. The McGill University Health Centre is affiliated with the faculty, and is composed of five teaching hospitals — the Royal Victoria Hospital which incorporates the Montreal Chest Institute, Montreal General Hospital, Montreal Children's Hospital, Montreal Neurological Hospital. Three other major health care facilities are also affiliated with the faculty: Jewish General Hospital, Douglas Hospital and St. Mary's Hospital. In April 2006, the Quebec government approved plans to commence the first phase of construction of the new, redeveloped McGill University Health Centre (MUHC).

MD Unknown

McGill University is a public research university located in Montreal, Quebec, Canada. Founded in 1821 during the British colonial era, the university bears the name of James McGill, a prominent Montreal merchant from Glasgow, Scotland and alumnus of Glasgow University, whose bequest formed the beginning of the university.

Graduate

Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.The school was founded by John Warren on September 19, 1782, with Benjamin Waterhouse, and Aaron Dexter.

Career History
Scientific Founder
Current

Affinivax, Inc. operates as a biotechnology company which develops novel conjugation technology. The company is headquartered in North Cambridge, MA.

Executive Chairman
Current

Genocea Biosciences, Inc. engages in the development and commercialization of cancer vaccines. It uses its proprietary technology platform ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-003, an investigational immunotherapy for the treatment of genital herpes; and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.

Chief Scientific Officer, ClearPath Development Company
Current

RRD International LLC provides alternative approach to drug development. The company was founded by Charles Finn in 2002 and is headquartered in Rockville, MD.

Boards & Committees
Member, Supervisory Board
2010 - 2011

Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems.The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.

Director
Prior

Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine and is headquartered in Cambridge, MA.

Director
Prior

MassBiologics, located in Boston, is the only non-profit, FDA-licensed manufacturer of vaccines in the United States. For over 100 years, MassBiologics has worked to improve public health through applied research, development and production of biologic products, including vaccines, plasma derivatives and most recently, monoclonal antibodies. MassBiologics currently manufactures Tetanus and Diphtheria Toxoids, Adsorbed (Td) vaccine and distribute nationwide.

Political Donations
$1,500
2008

Former Senator from Massachusetts

Investments
Details Hidden

Genocea Biosciences, Inc. engages in the development and commercialization of cancer vaccines. It uses its proprietary technology platform ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-003, an investigational immunotherapy for the treatment of genital herpes; and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by George Siber. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of George Siber's profile does not indicate a business or promotional relationship of any kind between RelSci and George Siber.